Orangekloud Technology Inc. Announces Nasdaq Delisting Determination Letter

Rhea-AI Summary

Orangekloud Technology (NASDAQ: ORKT) received a Staff Delisting Determination Letter on January 29, 2026, citing noncompliance with Nasdaq Listing Rule 5550(a)(2) because the securities closed below $1 for 30 consecutive business days.

The Staff noted a prior reverse stock split within the past year, making the company ineligible for the standard 180-day cure period. Orangekloud intends to request an oral hearing under Nasdaq Rule 5815 to stay delisting, will submit a written compliance plan, and may request a temporary exception; there is no assurance the Panel will approve the plan or exception. Trading continues under ORKT.

Positive

• Filing a request for an oral hearing under Rule 5815 stays suspension of trading
• Company securities continue trading normally on Nasdaq while appeal is pending
• Company will submit a written compliance plan and may request a temporary exception

Negative

• Received Staff Delisting Determination due to closing share price below $1 for 30 consecutive business days
• Prior reverse stock split within one year disqualifies the company from the 180-day cure period
• No assurance the Nasdaq Hearings Panel will approve the company’s plan or grant the requested exception

Key Figures

Minimum bid price: $1 per share Non-compliance period: 30 consecutive business days Standard cure window: 180-calendar day period +3 more

6 metrics

Minimum bid price $1 per share Nasdaq Listing Rule 5550(a)(2) threshold cited in delisting letter

Non-compliance period 30 consecutive business days Period ORKT traded below $1 before Staff Delisting Determination

Standard cure window 180-calendar day period Grace period not available due to prior reverse stock split

Disclosure deadline four business days Timeframe to publicly disclose deficiency and Staff Determination

Price change -28.28% Move in ORKT shares prior to this announcement

52-week range $0.6165 – $6.8 Positioning before news; current price near lower end

Market Reality Check

Price: $1.12 Vol: Volume 285,470 is 0.11x t...

low vol

$1.12 Last Close

Volume Volume 285,470 is 0.11x the 20-day average of 2,535,803, indicating relatively muted trading despite the headline. low

Technical Price at 1.12 is trading below the 200-day MA of 1.91, and sits 83.53% below the 52-week high of 6.8.

Peers on Argus

ORKT fell 28.28% while momentum peers like CXAI and NXPL showed gains above 5%. ...

2 Up

ORKT fell 28.28% while momentum peers like CXAI and NXPL showed gains above 5%. This divergence and lack of same-day peer news point to a company-specific reaction rather than a sector-wide move.

Market Pulse Summary

This announcement detailed that ORKT received a Nasdaq Staff Delisting Determination after trading b...

Analysis

This announcement detailed that ORKT received a Nasdaq Staff Delisting Determination after trading below $1 for 30 consecutive business days without eligibility for a new 180-day cure period. The company intended to appeal and submit a compliance plan, but there was no assurance of success. Investors may focus on the Panel outcome, any additional corporate actions to support the share price, and how management balances listing requirements with broader strategic and capital needs.

Key Terms

reverse stock split, nasdaq capital market, listing rule 5550(a)(2), nasdaq hearings panel

4 terms

reverse stock split financial

"the Company has effected a reverse stock split over the prior one-year period"

A reverse stock split is when a company reduces the number of its shares outstanding, making each share more valuable. For example, if you own 100 shares worth $1 each, a 1-for-10 reverse split would turn your 100 shares into 10 shares worth $10 each. Companies often do this to boost their stock price and appear more stable to investors.

nasdaq capital market regulatory

"to delist the Company’s common stock from the Nasdaq Capital Market (the “Nasdaq”)"

The Nasdaq Capital Market is a platform where smaller, emerging companies can list their shares for trading by investors. It provides these companies with access to funding and visibility, helping them grow, much like a local marketplace where new vendors can introduce their products to potential customers. For investors, it offers opportunities to discover early-stage companies with growth potential.

listing rule 5550(a)(2) regulatory

"thus not complying with Listing Rule 5550(a)(2)"

Listing Rule 5550(a)(2) is a Nasdaq listing standard that sets a minimum share-price requirement for securities to be listed or to remain listed on the Nasdaq Capital Market. It matters to investors because falling below that minimum can trigger delisting reviews or increased volatility, much like a safety bar on a ride — if a stock can’t meet the height requirement, it risks being removed from the exchange, which can reduce liquidity and access for buyers and sellers.

nasdaq hearings panel regulatory

"oral hearing before the Nasdaq Hearings Panel (the “Panel”)"

A Nasdaq hearings panel is a group of experts that reviews cases when a company's stock listing is at risk of being removed from the exchange. They evaluate whether the company has met certain standards and determine if it can keep trading on Nasdaq. This process matters to investors because it can affect a company's ability to raise money and maintain credibility in the market.

AI-generated analysis. Not financial advice.

Singapore, Feb. 04, 2026 (GLOBE NEWSWIRE) -- Orangekloud Technology Inc. (NASDAQ: ORKT) (“Orangekloud” or the “Company”), a Singapore-based technology company offering the eMOBIQ®️ No-Code platform for development of mobile applications, today announced that, on January 29, 2026, it received a Staff Delisting Determination Letter from the staff of Nasdaq Listing Qualifications (the “Staff”).

This Letter stated that, due to the Company’s securities having closed at less than $1 per share over the previous 30 consecutive business days and thus not complying with Listing Rule 5550(a)(2), and that the Company has effected a reverse stock split over the prior one-year period and therefore is not eligible to receive the 180-calendar day period otherwise allotted to demonstrate compliance under Listing Rule 5810(c)(3)(A), the Staff has determined that it will commence proceedings to delist the Company’s common stock from the Nasdaq Capital Market (the “Nasdaq”).

The Company intends to appeal the Staff Determination by filing a request for oral hearing before the Nasdaq Hearings Panel (the “Panel”) pursuant to Nasdaq Listing Rule 5815. Per Rule 5815(a)(1)(B), this request, once filed, will stay the suspension of trading or delisting of the Company’s securities pending the hearing and the Panel’s decision. In the meantime, the Company’s securities will continue to trade in the normal manner on the Nasdaq Capital Market under the symbol “ORKT.”

Per Listing Rule 5815(a)(5), the Company will submit to the Hearings Panel a written plan of compliance, and request that the Panel grant an exception to the listing standards for a limited time period, as permitted by Rule 5815(c)(1)(A). There can be no assurance, however, that the Panel will approve the Company’s plan to regain compliance and/or grant the requested exception, nor can there be any assurance that such plan will be successful if brought into effect.

The Company furnishes this announcement to satisfy its obligation under Listing Rule 5810(b) to make public disclosure of the subject deficiency and of the Staff Determination within four business days thereof.

About Orangekloud Technology Inc.

Orangekloud Technology Inc. (NASDAQ: ORKT) is a Singapore-based technology company which offers the eMOBIQ® No-Code platform to develop mobile applications specially designed for Small and Medium Enterprises (SMEs) and corporations. A suite of eMOBIQ® mobile applications designed to digitalize and streamline operations in warehousing, sales ordering, delivery, manufacturing, and other key areas. The industry sectors focused on include Food Services & Manufacturing, Precision Engineering, Construction, etc.

FORWARD-LOOKING STATEMENTS

Certain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to the expected trading commencement and closing dates. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Actual results may differ materially from those indicated by such forward-looking statements as a result of various important factors, including: the uncertainties related to market conditions and the completion of the public offering on the anticipated terms or at all, and other factors discussed in the “Risk Factors” section of the preliminary prospectus filed with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and OrangeKloud Technology Inc. specifically disclaims any obligation to update any forward-looking statement, whether as a result of new information, future events or otherwise, except as required by law.

Contacts

OrangeKloud Technology Inc. IR Contact:
Steven Chu, COO and IR Officer
70 Bendemeer Road #04-04 Luzerne
Singapore 339940
(+65) 6317 2050
Email: ir@orangekloud.com

Investor Relations Inquiries:
Skyline Corporate Communications Group, LLC
Scott Powell, President
1177 Avenue of the Americas, 5th Floor
New York, New York 10036
Office: (646) 893-5835
Email: info@skylineccg.com

FAQ

Why did Nasdaq issue a delisting determination for Orangekloud (ORKT) on January 29, 2026?

Nasdaq determined the company was noncompliant because its shares closed below $1 for 30 consecutive business days. According to the company, a prior reverse stock split within the past year also made it ineligible for the standard 180-day compliance period.

Will Orangekloud (ORKT) continue trading after the Nasdaq delisting determination?

Yes. The company’s securities will continue to trade normally on Nasdaq while the appeal process is pending. According to the company, filing a request for an oral hearing under Rule 5815 stays suspension of trading pending the Panel’s decision.

What steps is Orangekloud (ORKT) taking to avoid delisting after the Staff Determination?

Orangekloud intends to request an oral hearing and will submit a written compliance plan to the Hearings Panel. According to the company, it will also request a temporary exception under Rule 5815 to seek additional time to regain compliance.

Does the prior reverse stock split affect Orangekloud’s (ORKT) ability to cure the listing deficiency?

Yes. The Staff noted the reverse split occurred within the prior year and thus the company is not eligible for the 180-calendar day cure period. According to the company, this disqualification influenced the Staff’s delisting determination.

What are the chances Orangekloud (ORKT) will remain listed after the Nasdaq hearing?

There is no assurance the Hearings Panel will approve the company’s plan or grant an exception to listing standards. According to the company, the outcome depends on the Panel’s review of the submitted compliance plan and requested relief.